136 related articles for article (PubMed ID: 23427117)
1. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample.
Starcevic B; Ahrens BD; Butch AW
Drug Test Anal; 2013 May; 5(5):377-9. PubMed ID: 23427117
[No Abstract] [Full Text] [Related]
2. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens.
Thevis M; Gerace E; Thomas A; Beuck S; Geyer H; Schlörer N; Kearbey JD; Dalton JT; Schänzer W
Drug Test Anal; 2010; 2(11-12):589-98. PubMed ID: 20967890
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
[TBL] [Abstract][Full Text] [Related]
4. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.
Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D
Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
[TBL] [Abstract][Full Text] [Related]
6. Detection of selective androgen receptor modulator YK-11 in a doping control sample.
Sobolevsky T; Kucherova Y; Ahrens B
Drug Test Anal; 2024 Jun; 16(6):655-660. PubMed ID: 37946705
[No Abstract] [Full Text] [Related]
7. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
[TBL] [Abstract][Full Text] [Related]
8. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
Thevis M; Geyer H; Kamber M; Schänzer W
Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
[TBL] [Abstract][Full Text] [Related]
9. Reference standards to underpin the detection of steroid abuse by athletes.
Mackay LG
Anal Bioanal Chem; 2008 Jun; 391(3):911-3. PubMed ID: 18278486
[No Abstract] [Full Text] [Related]
10. The use of a simple backflush technology to improve sample throughput and system robustness in routine gas chromatography tandem mass spectrometry analysis of doping control samples.
Gray BP; Teale P
J Chromatogr A; 2010 Jul; 1217(28):4749-52. PubMed ID: 20627253
[TBL] [Abstract][Full Text] [Related]
11. Aryl-propionamide-derived selective androgen receptor modulators: liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes.
Kuuranne T; Leinonen A; Schänzer W; Kamber M; Kostiainen R; Thevis M
Drug Metab Dispos; 2008 Mar; 36(3):571-81. PubMed ID: 18086831
[TBL] [Abstract][Full Text] [Related]
12. Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample.
Cawley AT; Smart C; Greer C; Liu Lau M; Keledjian J
Drug Test Anal; 2016 Feb; 8(2):257-61. PubMed ID: 26456227
[No Abstract] [Full Text] [Related]
13. Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing.
Thevis M; Lohmann W; Schrader Y; Kohler M; Bornatsch W; Karst U; Schänzer W
Eur J Mass Spectrom (Chichester); 2008; 14(3):163-70. PubMed ID: 18708696
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.
Thevis M; Lagojda A; Kuehne D; Thomas A; Dib J; Hansson A; Hedeland M; Bondesson U; Wigger T; Karst U; Schänzer W
Rapid Commun Mass Spectrom; 2015 Jun; 29(11):991-9. PubMed ID: 26044265
[TBL] [Abstract][Full Text] [Related]
15. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
[TBL] [Abstract][Full Text] [Related]
16. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
[TBL] [Abstract][Full Text] [Related]
17. Stable isotope ratio analysis in sports anti-doping.
Cawley A
Drug Test Anal; 2012 Dec; 4(12):891-2. PubMed ID: 23255318
[No Abstract] [Full Text] [Related]
18. SARM-S4 and metabolites detection in sports drug testing: a case report.
Grata E; Perrenoud L; Saugy M; Baume N
Forensic Sci Int; 2011 Dec; 213(1-3):104-8. PubMed ID: 21816554
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
Van Eenoo P; Delbeke FT
J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry of selective androgen receptor modulators.
Thevis M; Schänzer W
J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
